Home/Filings/4/0000899243-22-019105
4//SEC Filing

Schwartz Jeffrey Lawrence 4

Accession 0000899243-22-019105

CIK 0001773427other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 6:23 PM ET

Size

9.0 KB

Accession

0000899243-22-019105

Insider Transaction Report

Form 4
Period: 2022-05-19
Schwartz Jeffrey Lawrence
Director10% Owner
Transactions
  • Award

    Common Stock

    2022-05-19+4,8185,924 total
  • Award

    Stock Option (Right to Buy)

    2022-05-19+15,31815,318 total
    Exercise: $35.42Exp: 2032-05-19Common Stock (15,318 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    4,831,307
Footnotes (3)
  • [F1]This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders. The RSUs shall vest in full on the earlier of (1) May 19, 2023 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.
  • [F2]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders. The options will vest in full on the earlier of (1) May 19, 2023 and (2) the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.
  • [F3]Represents shares of common stock held directly by BC SW, LP. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the general partner of BC SW, LP. Mr. Schwartz is a managing director of BCLSI. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC SW, LP. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Issuer

SpringWorks Therapeutics, Inc.

CIK 0001773427

Entity typeother

Related Parties

1
  • filerCIK 0001702957

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 6:23 PM ET
Size
9.0 KB